Literature DB >> 3263117

Imipenem as substrate and inhibitor of beta-lactamases.

J Monks1, S G Waley.   

Abstract

The interaction between imipenem, a carbapenem antibiotic, and two representative beta-lactamases has been studied. The first enzyme was beta-lactamase I, a class-A beta-lactamase from Bacillus cereus; imipenem behaved as a slow substrate (kcat. 6.7 min-1, Km 0.4 mM at 30 degrees C and at pH 7) that reacted by a branched pathway. There was transient formation of an altered species formed in a reversible reaction; this species was probably an acyl-enzyme in a slightly altered, but considerably more labile, conformation. The kinetics of the reaction were investigated by measuring both the concentration of the substrate and the activity of the enzyme, which fell and then rose again more slowly. The second enzyme was the chromosomal class-C beta-lactamase from Pseudomonas aeruginosa; imipenem was a substrate with a low kcat. (0.8 min-1) and a low Km (0.7 microM). Possible implications for the clinical use of imipenem are considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263117      PMCID: PMC1149301          DOI: 10.1042/bj2530323

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Catalytic and conformational properties of cross-linked derivatives of penicillinase.

Authors:  Y Klemes; N Citri
Journal:  Biochim Biophys Acta       Date:  1979-04-12

2.  Substrate-induced deactivation of penicillinases. Studies of beta-lactamase I by hydrogen exchange.

Authors:  P A Kiener; S G Waley
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

3.  Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept.

Authors:  C Frieden
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

4.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

5.  Mutant of Pseudomonas aeruginosa 18S that synthesizes type Id beta-lactamase constitutively.

Authors:  F Flett; N A Curtis; M H Richmond
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

6.  Acquisition of substrate-specific parameters during the catalytic reaction of penicillinase.

Authors:  N Citri; A Samuni; N Zyk
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

7.  Mechanism of substrate-induced inactivation of beta-lactamase I.

Authors:  P A Kiener; V Knott-Hunziker; S Petursson; S G Waley
Journal:  Eur J Biochem       Date:  1980-08

8.  Production of a variant of beta-lactamase II with selectively decreased cephalosporinase activity by a mutant of Bacillus cereus 569/H/9.

Authors:  G S Baldwin; G F Edwards; P A Kiener; M J Tully; S G Waley; E P Abraham
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

9.  Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  J Fisher; R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

10.  Separation, purification and properties of beta-lactamase I and beta-lactamase II from Bacillus cereus 569/H/9.

Authors:  R B Davies; E P Abraham
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

View more
  13 in total

1.  The kinetics of substrate-induced inactivation.

Authors:  S G Waley
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

Review 2.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

3.  A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.

Authors:  Krisztina M Papp-Wallace; Susana Mallo; Christopher R Bethel; Magdalena A Taracila; Andrea M Hujer; Ana Fernández; Julian A Gatta; Kerri M Smith; Yan Xu; Malcolm G P Page; Eric Desarbre; Germán Bou; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2013-11-13       Impact factor: 5.790

4.  Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.

Authors:  Michiyosi Nukaga; Christopher R Bethel; Jodi M Thomson; Andrea M Hujer; Anne Distler; Vernon E Anderson; James R Knox; Robert A Bonomo
Journal:  J Am Chem Soc       Date:  2008-08-30       Impact factor: 15.419

5.  Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.

Authors:  Sarah M Drawz; Maja Babic; Christopher R Bethel; Magda Taracila; Anne M Distler; Claudia Ori; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

6.  Interactions of biapenem with active-site serine and metallo-beta-lactamases.

Authors:  A Felici; M Perilli; B Segatore; N Franceschini; D Setacci; A Oratore; S Stefani; M Galleni; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2.

Authors:  Sabri B Erdemli; Radhika Gupta; William R Bishai; Gyanu Lamichhane; L Mario Amzel; Mario A Bianchet
Journal:  Structure       Date:  2012-10-25       Impact factor: 5.006

8.  Irreversible inactivation of beta-lactamase I from Bacillus cereus by chlorinated 6-spiroepoxypenicillins.

Authors:  L Gledhill; P Williams; B W Bycroft
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

Review 9.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  P Nordmann; E Ronco; T Naas; C Duport; Y Michel-Briand; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.